FindTrial
Sign In

Effect of dexmedetomidine intervention on myocardium in patients undergoing cardiac valve replacement after sevoflurane postconditioning

Effect of dexmedetomidine intervention on myocardium in patients undergoing cardiac valve replacement after sevoflurane postconditioning

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017747
Enrollment
Unknown
Registered
2018-08-12
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heart

Interventions

S group:SEV
DS group:DEX

Sponsors

The Second Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients undergoing elective cardiac valve replacement under cardiopulmonary bypass

Exclusion criteria

Exclusion criteria: Severe cardiac insufficiency, myocardial infarction, or liver and renal insufficiency, less than 18 years of age

Design outcomes

Primary

MeasureTime frame
Troponin I;Inflammatory markers;Oxidation-reduction;—

Countries

China

Contacts

Public ContactHongmei Zhou

The Second Hospital of Jiaxing

13867300139@163.com+86 13867300139

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026